Showing 1 to 2 of 2 clinical trials
CLINICAL TRIALS
    Trial No
    ClinicalTrials.gov ID
Phase Coordinator
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
    MK-3475-630/KEYNOTE-630
    NCT03833167
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
Paulina Garcia de Alba Graue
514-934-1934 poste 34573
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants With High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma
    MK-3475-630/KEYNOTE-630
    NCT03833167
     Recruiting
CIUSSS DE L'EST-DE-L'ILE-DE-MONTREAL
PAV. MAISONNEUVE/PAV. MARCEL-LAMOUREUX
Audrey Lamoureux
514-252-3400 poste 6258